20 70

Cited 8 times in

Cord blood cellular proliferative response as a predictive factor for atopic dermatitis at 12 months

 Hyo-Bin Kim ; Kang Mo Ahn ; Soo-Jong Hong ; Hye-Sung Won ; Hee Jin Park ; Kyung-Ju Lee ; Suk-Joo Choi ; Ja-Young Kwon ; Byoung-Ju Kim ; Ji-Won Kwon ; Hyung Young Kim ; Ju-Hee Seo ; Jinho Yu ; Youn Ho Shin ; Kyung Won Kim 
 Journal of Korean Medical Science, Vol.27(11) : 1320~1326, 2012 
Journal Title
 Journal of Korean Medical Science 
Issue Date
Since the risk of developing allergic disease increases in individuals exposed to allergens previously, even during the neonatal period, the immunologic status of a fetus may be important in the subsequent development of allergy. We evaluated the fetal factors to predict atopic dermatitis (AD) at 12 months in 412 infants of a COhort for Childhood Origin of Asthma and Allergic Diseases (COCOA) in the general Korean population. Cord blood mononuclear cells (CBMCs) were stimulated with ovalbumin and phytohemagglutinin and cellular proliferative response and concentrations of interleukin-13 and interferon-γ, were measured. The risk of developing AD was greater in boys than girls (OR 1.97, 95% CI 1.26-3.09), infants delivered by cesarean section than vaginally (OR 1.93, 95% CI 1.14-3.26) and infants with than without parental history of AD (OR 2.34, 95% CI 1.29-4.24). The CBMC proliferative response to phytohemagglutinin stimulation was higher in infants with than without AD (P = 0.048), but no difference was observed in ovalbumin-stimulated cells (P = 0.771). Risk factors for the development of AD at 12 months include male gender, delivery by cesarean section and parental history of AD. Increased CBMC proliferative response to phytohemagglutinin stimulation may predict the development of AD at 12 months.
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Obstetrics & Gynecology
1. 연구논문 > 1. College of Medicine > Dept. of Pediatrics
Yonsei Authors
사서에게 알리기
Files in This Item:
RIS (EndNote)
XLS (Excel)


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.